Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Parkinson's patients may sharpen driving skills with simulator training

NCT ID NCT07463755

Symptom relief Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether 10 sessions of low-fidelity driving simulator training can improve driving performance, confidence, and thinking skills in people with Parkinson's disease. 36 participants will be randomly assigned to either the simulator training or a waitlist group. Researchers will compare driving tests and cognitive scores before and after the training period.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low-fidelity driving simulator training
What this could lead to
If it works, this could point toward a non-drug therapy to help people with Parkinson's drive more safely and confidently.
What could go wrong
This is a very small pilot study (36 people) with no blinding. The training is on a basic simulator, so improvements may not carry over to real driving. Results are preliminary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals with Parkinson's disease diagnosed by a movement disorder specialist. * Diagnosis of PD was based on the UK Brain Bank Diagnostic Criteria. * Hoehn and Yahr stage 1 to 3 in the medication ON state with no troublesome dyskinesia. * Minimum binocular acuity of 20/40 or better at least in one eye according to the Kansas DMV statutes. * Montreal Cognitive Assessment (MoCA) ≥ 20. * Ambulates independently with or without walking aids. * Possess a valid driver's license. Exclusion Criteria: * Any concomitant neurological comorbidity, such as stroke, traumatic brain injury, or multiple sclerosis, that would hinder driving. * Atypical forms of Parkinsonism * History of substance abuse in the last 10 years. * History of uncontrolled psychiatric problems * Undergone deep brain stimulation or focused ultrasound treatment * Uncontrolled diabetes mellitus

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson'S disease (PD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson'S disease (PD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mobility and Falls Lab

    Kansas City, Kansas, 66103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.